Rapid Antidepressant-Like Potential of Chaihu Shugan San Depends on Suppressing Glutamate Neurotransmission and Activating Synaptic Proteins in Hippocampus of Female Mice
Chinese Journal of Integrative Medicine · 2024-08 · 30 (8) · 692-700
DOI: 10.1007/s11655-024-3906-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Journal of Integrative Medicine, online erschienen am 11.05.2024. Verfasst von Chao Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chinese Medicine Preparations, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medi…. Hauptthemen laut MEDLINE: Antidepressive Agents, Hippocampus, Glutamic Acid, Synaptic Transmission. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: To explore the rapid antidepressant potential and the underlying mechanism of Chaihu Shugan San (CSS) in female mice. METHODS: Liquid chromatography mass spectrometry (LC-MS)/MS was used to determine the content of main components in CSS to determine its stability. Female C57BL/6J mice were randomly divided into 4 groups, including control (saline), vehicle (saline), CSS (4 g/kg) and ketamine (30 mg/kg) groups. Mice were subjected to irregular stress stimulation for 4 weeks to establish the chronic mild stress (CMS) model, then received a single administration of drugs. Two hours later, the behavioral tests were performed, including open field test, tail suspension test (TST), forced swimming test (FST), novelty suppression feeding test (NSF), and sucrose preference test (SPT). Western blot analysis was used to detect the expression levels of N-methyl-D-aspartate receptor (NMDA) subtypes [N-methyl-D-aspartate receptor 1 (NR1), NR2A, NR2B], synaptic proteins [synapsin1 and post synaptic density protein 95 (PSD95)], and brain-derived neurotrophic factor (BDNF). Moreover, the rapid antidepressant effect of CSS was tested by pharmacological technologies and optogenetic interventions that activated glutamate receptors, NMDA. RESULTS: Compared with the vehicle group, a single administration of CSS (4 g/kg) reversed all behavioral defects in TST, FST, SPT and NSF caused by CMS (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chinese Medicine Preparations, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210029, China.
- College of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, 210046, China.
- Department of Chinese Medicine, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China.
- Department of Chinese Medicine Preparations, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210029, China. fsyy00682@njucm.edu.cn.
Zitieren
APA
Lu, C., Gao, Z. W., Xing, S., Wang, H. H., Huang, Y. K., Zhou, H., & Wu, L. (2024). Rapid Antidepressant-Like Potential of Chaihu Shugan San Depends on Suppressing Glutamate Neurotransmission and Activating Synaptic Proteins in Hippocampus of Female Mice. Chinese Journal of Integrative Medicine, 30(8), 692-700. https://doi.org/10.1007/s11655-024-3906-2
Vancouver
Lu C, Gao ZW, Xing S, Wang HH, Huang YK, Zhou H, et al. Rapid Antidepressant-Like Potential of Chaihu Shugan San Depends on Suppressing Glutamate Neurotransmission and Activating Synaptic Proteins in Hippocampus of Female Mice. Chinese Journal of Integrative Medicine. 2024;30(8):692-700. doi:10.1007/s11655-024-3906-2
BibTeX
@article{Lu2024,
author = {Lu, Chao and Gao, Zi-Wei and Xing, Shan and Wang, Hui-Hui and Huang, Yun-Ke and Zhou, Hang and Wu, Lei},
title = {Rapid Antidepressant-Like Potential of Chaihu Shugan San Depends on Suppressing Glutamate Neurotransmission and Activating Synaptic Proteins in Hippocampus of Female Mice},
journal = {Chinese Journal of Integrative Medicine},
year = {2024},
volume = {30},
number = {8},
pages = {692--700},
doi = {10.1007/s11655-024-3906-2}
}
EUVIMED